By [Your Name/Journalist Name]
December 1, 2025
TEANECK, N.J. — In the landscape of non-profit healthcare advocacy, few stories are as poignant or as transformative as that of Sharsheret, the national Jewish breast cancer and ovarian cancer organization. This December, as the organization marks a decade since the passing of its visionary founder, Rochelle Shoretz, her sons, Shlomo and Dovid Mirsky, have issued a powerful call to action. Their year-end appeal is not merely a request for funding; it is a testament to a movement that began at a dining room table and has since grown into an international lifeline for hundreds of thousands of families.
The 2025 year-end campaign comes at a critical juncture for the organization. As Sharsheret now reaches more than 275,000 individuals annually, the Mirsky brothers are reflecting on their mother’s legacy, the "taboo" nature of cancer in the early 2000s, and the vital importance of ensuring that no woman—or family—faces a cancer diagnosis in isolation.
Main Facts: From Personal Crisis to International Movement
The core of the Mirsky brothers’ appeal centers on the profound evolution of Sharsheret. Founded in 2001, the organization was born out of Rochelle Shoretz’s personal struggle to find a community that understood the intersection of a life-threatening illness with the nuances of Jewish life. At the age of 28, while serving as a law clerk for Supreme Court Justice Ruth Bader Ginsburg, Shoretz was diagnosed with breast cancer. She quickly realized that while medical resources existed, the psychosocial and cultural support systems for young Jewish women were virtually non-existent.
Today, Sharsheret (Hebrew for "chain") serves as that missing link. The organization provides a suite of services, including:
- Peer Support: Matching newly diagnosed women with survivors who share similar backgrounds.
- Genetic Counseling: Addressing the high prevalence of BRCA gene mutations within the Ashkenazi Jewish community.
- The Busy Box Program: A resource specifically mentioned by Shlomo and Dovid, which provides age-appropriate materials to help children understand a parent’s diagnosis.
- Financial Assistance: Helping families navigate the hidden costs of cancer treatment.
As of December 2025, Sharsheret has expanded its reach to all 50 U.S. states and several international territories, moving from a localized support group to a pillar of the global health community.
Chronology: The Journey of Rochelle Shoretz and Sharsheret
The history of Sharsheret is inextricably linked to the personal timeline of Rochelle Shoretz and her family. To understand the weight of the current appeal, one must look back at the milestones that shaped the organization.
2001: The Diagnosis and the Gap in Care
When Rochelle Shoretz was diagnosed in 2001, her sons Shlomo and Dovid were just five and three years old, respectively. At the time, cancer was often discussed in hushed tones within many communities. Shoretz found herself searching for a peer who could discuss not just chemotherapy, but how to parent young children while undergoing treatment, and how to maintain a religious lifestyle amidst a medical crisis.
She eventually found a mentor in Lauryn Weiser, a young Jewish mother who was further along in her treatment. This connection was the spark. Shoretz realized that if she needed this connection, thousands of others did too.
2001–2010: The Dining Room Table Era
Sharsheret began with five women meeting in Shoretz’s dining room. The initial goal was modest: to link young Jewish women together. However, the demand was overwhelming. Within years, the organization began developing specialized programs like "Best Face Forward" (addressing the cosmetic side effects of treatment) and "Thriving and Surviving" (focusing on post-treatment life).
2015: A Profound Loss
Rochelle Shoretz passed away in 2015 at the age of 42. Her death was a significant blow to the advocacy community, but she had spent the previous 14 years ensuring that Sharsheret was built on a foundation strong enough to outlast its founder. She left behind a legacy of "living out loud," encouraging women to take charge of their health and their narratives.
2015–2025: Exponential Growth
In the decade following Shoretz’s death, Sharsheret has scaled its operations. The organization transitioned from focusing primarily on breast cancer to including ovarian cancer, acknowledging the shared genetic risks associated with BRCA mutations. The "Busy Box" program, which once served a handful of families, has now reached thousands of children, providing a sense of normalcy during a parent’s illness.
Supporting Data: The Impact of Culturally Competent Care
The necessity of Sharsheret is backed by stark medical data. Research has consistently shown that 1 in 40 individuals of Ashkenazi Jewish descent carries a BRCA1 or BRCA2 gene mutation—a rate ten times higher than that of the general population. These mutations significantly increase the risk of developing breast, ovarian, pancreatic, and prostate cancers.
By focusing on this specific demographic, Sharsheret has been able to:
- Increase Early Detection: Through aggressive education campaigns, more women in the Jewish community are seeking genetic testing and regular screenings.
- Improve Mental Health Outcomes: Studies in psycho-oncology suggest that peer-to-peer support reduces clinical depression and anxiety in cancer patients. Sharsheret’s model of "linking" women is now studied as a gold standard in specialized care.
- Support the Family Unit: The Busy Box program, highlighted by the Mirsky brothers, addresses the "collateral damage" of cancer. By providing toys, journals, and guides for children, Sharsheret mitigates the trauma experienced by the youngest members of the family.
In 2025 alone, Sharsheret’s digital resources and webinars have reached over 275,000 people, a staggering increase from its humble beginnings.
Official Responses: A Call from the Next Generation
In their joint statement, Shlomo and Dovid Mirsky emphasized that while their mother is no longer here to see the organization’s success, her vision remains the driving force.
"We were personally served by Sharsheret, which provided life-changing assistance to our family during Mom’s fight against cancer," the brothers stated. "As young children, receiving Sharsheret’s Busy Box helped distract us from the difficult realities of Mom’s cancer treatments."
They reflected on the milestones their mother missed—graduations, the birth of grandchildren, and the organization’s growth—but noted that the work of Sharsheret keeps her spirit alive. "What started as five women around our dining room table has turned into an international movement. We know that thanks to your generosity, Mom is looking down with pride as we build a healthier and brighter future for the next generation."
The year-end appeal (link.Sharsheret.org/EOY) is designed to fund the next chapter of this growth, ensuring that the "chain" remains unbroken as the organization looks toward 2026.
Implications: The Future of Specialized Cancer Advocacy
The success of Sharsheret and the continued involvement of the founder’s family have broader implications for the future of healthcare advocacy.
1. The Power of "Niche" Advocacy
Sharsheret has proven that "niche" organizations can have a massive impact. By focusing on the specific cultural, religious, and genetic needs of the Jewish community, they have created a model that other ethnic and cultural groups are now emulating to address their own specific health disparities.
2. Breaking the Taboo
The transition from cancer being a "taboo subject" in 2001 to a matter of public conversation in 2025 is one of Sharsheret’s greatest achievements. This cultural shift allows for better preventative care and reduces the shame often associated with illness in tight-knit communities.
3. Sustainability Through Legacy
The fact that Sharsheret has not only survived but thrived ten years after the loss of its founder demonstrates the importance of institutionalizing a mission. The Mirsky brothers’ appeal highlights how the next generation can pivot from being "beneficiaries" of a cause to its primary advocates.
4. The Role of Year-End Giving
For non-profits like Sharsheret, year-end donations are vital. These funds dictate the budget for the upcoming year’s outreach, genetic counseling sessions, and the assembly of thousands of Busy Boxes. As the brothers noted, these contributions ensure that "thousands of families just like ours have Sharsheret to lean on in their time of need."
Conclusion
As the sun sets on 2025, the story of Rochelle Shoretz and the continued work of Sharsheret serves as a beacon of hope. From a small support group to an international powerhouse, the organization remains dedicated to the idea that no one should face cancer alone. Shlomo and Dovid Mirsky’s plea is a reminder that while medicine may treat the body, community heals the soul. Through their mother’s legacy, they are not just looking back at the past 24 years; they are building a "healthier and brighter future" for the thousands of families yet to come.
To support Sharsheret’s mission and contribute to their year-end campaign, visit link.Sharsheret.org/EOY.
About the Author
